Telesforo Bacchella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Telesforo Bacchella has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Marcel Cerqueira Cesar Machado
Universidade de São Paulo, Brasil
4 shared publications - Wellington Andraus
Universidade de São Paulo, Brazil
3 shared publications - Estela Regina Ramos Figueira
Universidade de São Paulo, Brazil
2 shared publications - Fabio Ferrari Makdissi
Hospital Nove de Julho, Brasil
2 shared publications - Ivan Cecconello
Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
2 shared publications - José Jukemura
Universidade de São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 36, e1783
ROBOTIC ASSISTED VERSUS LAPAROSCOPIC DISTAL PANCREATECTOMY: A RETROSPECTIVE STUDY
BACKGROUND: Minimally invasive distal pancreatectomy (MIDP) is associated with less blood loss and faster functional recovery. However, the benefits of robotic assisted distal pancreatectomy (RDP) over laparoscopic distal pancreatectomy (LDP) are unknown. AIMS: To compare RDP versus LDP for surgical treatment of benign lesions, pre-malignant and borderline malignant pancreatic neoplasias. METHODS: This is a retrospective study comparing LDP with RDP. Main outcomes were overall morbidity and overall costs. Secondary outcomes were pancreatic fistula (PF), infectious complications, readmission, operative time (OT) and length of hospital stay (LOS). RESULTS: Thirty patients submitted to LDP and 29 submitted to RDP were included in the study. There was no difference regarding preoperative characteristics. There was no difference regarding overall complications (RDP – 72,4% versus LDP – 80%, p=0,49). Costs were superior for patients submitted to RDP (RDP=US$ 6,688 versus LDP=US$ 6,149, p=0,02), mostly due to higher costs of surgical materials (RDP=US$ 2,364 versus LDP=1,421, p=0,00005). Twenty-one patients submitted to RDP and 24 to LDP developed pancreatic fistula (PF), but only 4 RDP and 7 LDP experienced infectious complications associated with PF. OT (RDP=224 min. versus LDP=213 min., p=0.36) was similar, as well as conversion to open procedure (1 RDP and 2 LDP). CONCLUSIONS: The postoperative morbidity of robotic distal pancreatectomy is comparable to laparoscopic distal pancreatectomy. However, the costs of robotic distal pancreatectomy are slightly higher.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 36, e1783
Open AccessROBOTIC ASSISTED VERSUS LAPAROSCOPIC DISTAL PANCREATECTOMY: A RETROSPECTIVE STUDY
BACKGROUND: Minimally invasive distal pancreatectomy (MIDP) is associated with less blood loss and faster functional recovery. However, the benefits of robotic assisted distal pancreatectomy (RDP) over laparoscopic distal pancreatectomy (LDP) are unknown. AIMS: To compare RDP versus LDP for surgical treatment of benign lesions, pre-malignant and borderline malignant pancreatic neoplasias. METHODS: This is a retrospective study comparing LDP with RDP. Main outcomes were overall morbidity and overall costs. Secondary outcomes were pancreatic fistula (PF), infectious complications, readmission, operative time (OT) and length of hospital stay (LOS). RESULTS: Thirty patients submitted to LDP and 29 submitted to RDP were included in the study. There was no difference regarding preoperative characteristics. There was no difference regarding overall complications (RDP – 72,4% versus LDP – 80%, p=0,49). Costs were superior for patients submitted to RDP (RDP=US$ 6,688 versus LDP=US$ 6,149, p=0,02), mostly due to higher costs of surgical materials (RDP=US$ 2,364 versus LDP=1,421, p=0,00005). Twenty-one patients submitted to RDP and 24 to LDP developed pancreatic fistula (PF), but only 4 RDP and 7 LDP experienced infectious complications associated with PF. OT (RDP=224 min. versus LDP=213 min., p=0.36) was similar, as well as conversion to open procedure (1 RDP and 2 LDP). CONCLUSIONS: The postoperative morbidity of robotic distal pancreatectomy is comparable to laparoscopic distal pancreatectomy. However, the costs of robotic distal pancreatectomy are slightly higher.
- 1 September 2017
- Published by Elsevier in Pancreatology
- Vol. 17 (4) , S52
Surgical management of chronic pancreatitis
- 1 September 2017
- Published by Elsevier in Pancreatology
- Vol. 17 (4) , S52
Surgical management of chronic pancreatitis
- Open Access
PORTAL VEIN ANEURYSM
- 1 May 2004
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (4) , 931-932
Early mortality in liver transplantation: bilirubin as predictor of outcome
- 1 May 2004
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (4) , 931-932
Early mortality in liver transplantation: bilirubin as predictor of outcome
- 1 May 2004
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (4) , 951-952
Biliary reconstruction without T-tube in liver transplantation
- 1 May 2004
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (4) , 951-952
Biliary reconstruction without T-tube in liver transplantation
- Open Access
- 1 January 2003
- Published by FapUNIFESP (SciELO) in Revista Do Hospital Das Clinicas
- Vol. 58 (3) , 179-184
Critical analysis of the allocation policy for liver transplantation in Brazil
Liver transplantation is now the standard treatment for end-stage liver disease. Given the shortage of liver donors and the progressively higher number of patients waiting for transplantation, improvements in patient selection and optimization of timing for transplantation are needed. Several solutions have been suggested, including increasing the donor pool; a fair policy for allocation, not permitting variables such as age, gender, and race, or third-party payer status to play any role; and knowledge of the natural history of each liver disease for which transplantation is offered. To observe ethical rules and distributive justice (guarantee to every citizen the same opportunity to get an organ), the "sickest first" policy must be used. Studies have demonstrated that death has no relationship with waiting time, but rather with the severity of liver disease at the time of inclusion. Thus, waiting time is no longer part of the United Network for Organ Sharing distribution criteria. Waiting time only differentiates between equally severely diseased patients. The authors have analyzed the waiting list mortality and 1-year survival for patients of the State of São Paulo, from July 1997 through January 2001. Only the chronological criterion was used. According to "Secretaria de Estado da Saúde de São Paulo" data, among all waiting list deaths, 82.2% occurred within the first year, and 37.6% within the first 3 months following inclusion. The allocation of livers based on waiting time is neither fair nor ethical, impairs distributive justice and human rights, and does not occur in any other part of the world.
- 1 January 2003
- Published by FapUNIFESP (SciELO) in Revista Do Hospital Das Clinicas
- Vol. 58 (3) , 179-184
Open AccessCritical analysis of the allocation policy for liver transplantation in Brazil
Liver transplantation is now the standard treatment for end-stage liver disease. Given the shortage of liver donors and the progressively higher number of patients waiting for transplantation, improvements in patient selection and optimization of timing for transplantation are needed. Several solutions have been suggested, including increasing the donor pool; a fair policy for allocation, not permitting variables such as age, gender, and race, or third-party payer status to play any role; and knowledge of the natural history of each liver disease for which transplantation is offered. To observe ethical rules and distributive justice (guarantee to every citizen the same opportunity to get an organ), the "sickest first" policy must be used. Studies have demonstrated that death has no relationship with waiting time, but rather with the severity of liver disease at the time of inclusion. Thus, waiting time is no longer part of the United Network for Organ Sharing distribution criteria. Waiting time only differentiates between equally severely diseased patients. The authors have analyzed the waiting list mortality and 1-year survival for patients of the State of São Paulo, from July 1997 through January 2001. Only the chronological criterion was used. According to "Secretaria de Estado da Saúde de São Paulo" data, among all waiting list deaths, 82.2% occurred within the first year, and 37.6% within the first 3 months following inclusion. The allocation of livers based on waiting time is neither fair nor ethical, impairs distributive justice and human rights, and does not occur in any other part of the world.
- Open Access
- 1 June 1998
- Published by Elsevier in Revista da Associação Médica Brasileira
- Vol. 44 (2) , 159-166
Tratamento cirúrgico dos insulinomas -- estudo de 59 casos
- 1 June 1998
- Published by Elsevier in Revista da Associação Médica Brasileira
- Vol. 44 (2) , 159-166
Open AccessTratamento cirúrgico dos insulinomas -- estudo de 59 casos